Drug:
Reaction: GASTROINTESTINAL DISORDER
20250101 - 20251231
No. 301 - 400
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
301 | 25079969 |
US |
2 | |
Gastrointestinal hypomotility, Constipation, Flatulence, Regurgitation, Gastrointestinal disorder, Product prescribing issue, |
||||
PROGESTERONE, PROGESTERONE, |
||||
302 | 25080124 |
CA |
44 | 2 |
Respiratory disorder, Liver disorder, Hepatic cirrhosis, Liver injury, Lupus-like syndrome, Rheumatoid arthritis, Pulmonary fibrosis, Breast cancer stage III, Colitis ulcerative, Crohn^s disease, Deep vein thrombosis postoperative, Porphyria acute, Lower respiratory tract infection, Lupus vulgaris, Pericarditis, Pneumonia, Muscular weakness, Psoriatic arthropathy, Retinitis, Grip strength, Ear infection, Drug tolerance decreased, Delirium, Helicobacter infection, Sleep disorder due to a general medical condition, Arthropathy, Asthenia, Gastrointestinal disorder, General physical health deterioration, Blood cholesterol increased, Grip strength decreased, Hand deformity, Gait disturbance, Foot deformity, Hypercholesterolaemia, Folliculitis, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Fibromyalgia, Irritable bowel syndrome, Joint range of motion decreased, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUOROMETHOLONE, RITUXIMAB, RITUXIMAB, |
||||
303 | 25080143 |
US |
50 | 1 |
Neoplasm malignant, Fatigue, Confusional state, Gastrointestinal disorder, Weight decreased, Decreased appetite, Social problem, Papule, Starvation, |
||||
EMPAGLIFLOZIN, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
304 | 25080205 |
CA |
40 | 2 |
Breast cancer stage II, Psoriatic arthropathy, Type 2 diabetes mellitus, Systemic lupus erythematosus, Hepatitis, Liver injury, Epilepsy, Lower respiratory tract infection, Duodenal ulcer perforation, Pneumonia, Pericarditis, Coeliac disease, Rheumatic fever, Pemphigus, Rheumatoid arthritis, Urticaria, Stomatitis, Helicobacter infection, Wound infection, Vomiting, Pain in extremity, Onychomycosis, Blepharospasm, Synovitis, Peripheral swelling, Depression, Hypertension, Hepatic enzyme increased, Blood cholesterol increased, Adverse reaction, Malaise, Hypersensitivity, Grip strength decreased, Alopecia, Headache, Obesity, Peripheral venous disease, Diarrhoea, Nasopharyngitis, Paraesthesia, Lung disorder, Muscular weakness, Dizziness, Asthenia, Musculoskeletal stiffness, Gastrointestinal disorder, Arthropathy, Hand deformity, Injection site reaction, Inflammation, Blister, General physical health deterioration, Bursitis, Mobility decreased, Liver function test increased, Infusion related reaction, Swelling, Memory impairment, Joint swelling, Live birth, Maternal exposure during pregnancy, Intentional product use issue, Normal newborn, Drug-induced liver injury, Irritable bowel syndrome, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, CANDESARTAN, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, SECUKINUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, SECUKINUMAB, |
||||
305 | 25080217 |
US |
||
Gastrointestinal disorder, Anxiety, |
||||
306 | 25080282 |
DE |
74 | 1 |
Gastrointestinal disorder, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
307 | 25083530 |
1 | ||
Medical procedure, Gastrointestinal disorder, Haemarthrosis, |
||||
308 | 25083688 |
1 | ||
Medical procedure, Gastrointestinal disorder, Influenza, Haemarthrosis, |
||||
TADALAFIL, DUPILUMAB, EMICIZUMAB, |
||||
309 | 25083862 |
1 | ||
Influenza, Gastrointestinal disorder, Haemarthrosis, |
||||
DUPILUMAB, TADALAFIL, EMICIZUMAB, |
||||
310 | 25083917 |
1 | ||
Gastrointestinal disorder, |
||||
PIRFENIDONE, |
||||
311 | 25071801 |
US |
71 | 2 |
Tooth loss, Inability to afford medication, Bruxism, Product use in unapproved indication, Gastrointestinal disorder, Body height decreased, |
||||
DEUTETRABENAZINE, |
||||
312 | 25071865 |
CN |
55 | |
Myelosuppression, Gastrointestinal disorder, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, TRASTUZUMAB, |
||||
313 | 25072038 |
US |
62 | 1 |
Asthenia, Sleep disorder, Head discomfort, Gastrointestinal disorder, Drug ineffective, |
||||
GALCANEZUMAB-GNLM, |
||||
314 | 25072064 |
US |
39 | 2 |
Flatulence, Gastrointestinal disorder, |
||||
INAVOLISIB, PALBOCICLIB, FULVESTRANT, DENOSUMAB, |
||||
315 | 25072406 |
US |
2 | |
Gastrointestinal disorder, Muscular weakness, |
||||
OMAVELOXOLONE, |
||||
316 | 25072890 |
US |
86 | 2 |
Atrial fibrillation, Gastrointestinal disorder, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, ATORVASTATIN CALCIUM, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE, MACITENTAN, METOPROLOL SUCCINATE, TADALAFIL, ESCITALOPRAM, APIXABAN, OXYGEN, 0XYGEN, IRON, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LORATADINE, LORATADINE ORAL, |
||||
317 | 25072899 |
US |
76 | 2 |
Gastrointestinal disorder, Diarrhoea, |
||||
DULAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
318 | 25073082 |
US |
2 | |
Gastrointestinal disorder, Pruritus, |
||||
ADALIMUMAB, |
||||
319 | 25073086 |
FR |
||
Small intestinal stenosis, General physical health deterioration, Disease recurrence, Gastrointestinal disorder, Diarrhoea, Weight decreased, Abdominal pain, Drug ineffective, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
320 | 25073512 |
CA |
||
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fluid retention, Fibromyalgia, Folliculitis, Gait disturbance, Gastrointestinal disorder, Gait inability, General physical health deterioration, General symptom, Grip strength decreased, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriatic arthropathy, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid factor positive, Rheumatoid arthritis, Sleep disorder, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Systemic lupus erythematosus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, X-ray abnormal, Wound infection, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM, ERGOCALCIFEROL, LANSOPRAZOLE, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, LORAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
321 | 25074116 |
US |
||
Impaired gastric emptying, Tremor, Depression, Gastrointestinal disorder, Product storage error, |
||||
EXENATIDE, |
||||
322 | 25074122 |
CA |
27 | 2 |
Rectal haemorrhage, Inappropriate schedule of product administration, Diarrhoea, Gastrointestinal disorder, Vomiting, Faeces discoloured, Abdominal pain lower, Incorrect dose administered, Vomiting, |
||||
RESLIZUMAB, RESLIZUMAB, |
||||
323 | 25074649 |
|||
Gastrointestinal disorder, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
324 | 25074661 |
AT |
66 | 2 |
Neoplasm progression, Chills, Myalgia, Nausea, Abnormal faeces, Gastrointestinal disorder, Disease risk factor, Malignant peritoneal neoplasm, Back pain, Ileus, |
||||
MIRVETUXIMAB SORAVTANSINE, MIRVETUXIMAB SORAVTANSINE, |
||||
325 | 25074836 |
CA |
1 | |
Blood creatine phosphokinase increased, Transaminases increased, Acute kidney injury, Blood bilirubin increased, Hypotension, Gastrointestinal disorder, Hepatobiliary disease, |
||||
326 | 25075243 |
CN |
||
Neutropenia, Leukopenia, Hypokalaemia, Cervix carcinoma, Febrile neutropenia, Thrombocytopenia, Injection site pain, Gastrointestinal disorder, Transaminases abnormal, Anaemia, Bone pain, Arthralgia, |
||||
FILGRASTIM, PEGFILGRASTIM, CISPLATIN, CARBOPLATIN, |
||||
327 | 25075279 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, Coeliac disease, Condition aggravated, Drug intolerance, Drug-induced liver injury, Dyspepsia, Fatigue, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hypersensitivity, Hypertension, Insomnia, Joint swelling, Malaise, Maternal exposure during pregnancy, Musculoskeletal stiffness, Nail disorder, Product label confusion, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, CALCIUM CARBONATE, CALCIUM CARBONATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
328 | 25075803 |
CO |
71 | 2 |
Gastrointestinal disorder, |
||||
ALIROCUMAB, |
||||
329 | 25075855 |
US |
92 | 1 |
Death, Gastrointestinal disorder, Inflammation, Infection, |
||||
PANCRELIPASE, |
||||
330 | 25076647 |
US |
72 | 2 |
Colon cancer, Visual impairment, Gastrointestinal disorder, |
||||
INSULIN LISPRO, |
||||
331 | 25076782 |
US |
74 | 1 |
Neuropathy peripheral, Insomnia, Gastrointestinal disorder, Off label use, |
||||
POMALIDOMIDE, POMALIDOMIDE, |
||||
332 | 25076825 |
US |
75 | 2 |
Gastrointestinal disorder, |
||||
ABATACEPT, ROSUVASTATIN, ROSUVASTATIN, |
||||
333 | 25078289 |
2 | ||
Gastrointestinal disorder, |
||||
ICATIBANT ACETATE, |
||||
334 | 25065948 |
IT |
70 | 2 |
Gastrointestinal disorder, Lipase increased, Influenza, Amylase increased, Productive cough, |
||||
RISANKIZUMAB-RZAA, BISOPROLOL FUMARATE, MAGNESIUM, |
||||
335 | 25065958 |
CA |
70 | 2 |
Small intestinal resection, Joint swelling, Pain, Crohn^s disease, Postoperative abscess, Gastrointestinal disorder, |
||||
UPADACITINIB, PREDNISONE, |
||||
336 | 25066276 |
US |
||
Nephrolithiasis, Gastrointestinal disorder, Vomiting, |
||||
TIRZEPATIDE, |
||||
337 | 25066475 |
US |
2 | |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
338 | 25066535 |
CA |
47 | 2 |
Body temperature decreased, COVID-19, Gastrointestinal disorder, Generalised oedema, Inappropriate schedule of product administration, Inflammation, Malaise, Urticaria, |
||||
OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, |
||||
339 | 25066551 |
US |
82 | 1 |
Gastrointestinal disorder, Off label use, |
||||
LENALIDOMIDE, |
||||
340 | 25066561 |
US |
61 | 2 |
Product contamination, Gastrointestinal disorder, Pyrexia, Chills, Malaise, Nausea, Vomiting, Diarrhoea, Recalled product administered, |
||||
ZOLPIDEM TARTRATE, |
||||
341 | 25066590 |
DE |
1 | |
Insomnia, Cough, Bronchitis, Gastrointestinal disorder, Burning sensation, Gastrointestinal lymphoma, |
||||
RITUXIMAB-PVVR, |
||||
342 | 25066761 |
GB |
60 | 2 |
Gastrointestinal disorder, Malaise, |
||||
EZETIMIBE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE FUROATE, LANSOPRAZOLE, PROPRANOLOL HYDROCHLORIDE, ROSUVASTATIN, ESTRADIOL, |
||||
343 | 25066862 |
CA |
||
Diarrhoea, Gastrointestinal disorder, Hypomagnesaemia, Immune-mediated enterocolitis, Immune-mediated lung disease, |
||||
DURVALUMAB, DURVALUMAB, AMOXICILLIN, CEFADROXIL, IPILIMUMAB, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, NIVOLUMAB, TRAMETINIB, ALDESLEUKIN, |
||||
344 | 25067301 |
US |
||
Blindness, Hypertension, Blood cholesterol abnormal, Headache, Gastrointestinal disorder, Intervertebral disc protrusion, |
||||
APIXABAN, |
||||
345 | 25067391 |
HU |
||
Alanine aminotransferase increased, Pancreatic disorder, Suicidal ideation, Gastrointestinal disorder, Tendonitis, Osteopenia, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BUDESONIDE, |
||||
346 | 25067412 |
US |
48 | 2 |
Dyspepsia, Urinary tract infection, Gastrointestinal disorder, |
||||
PANCRELIPASE, |
||||
347 | 25067477 |
CA |
80 | 1 |
Mobility decreased, Terminal state, Faecaloma, Pain, Hernia, Gastrointestinal disorder, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
348 | 25067509 |
US |
||
Hospitalisation, Gastrointestinal disorder, Hernia, Haemorrhage, Epigastric discomfort, Dry mouth, Feeding disorder, Ulcer, |
||||
BELIMUMAB, |
||||
349 | 25067631 |
JP |
66 | |
Gastrointestinal disorder, |
||||
DURVALUMAB, TREMELIMUMAB, |
||||
350 | 25067676 |
CA |
1 | |
Hepatobiliary disease, Acute kidney injury, Blood bilirubin increased, Blood creatine phosphokinase increased, Gastrointestinal disorder, Hypotension, Transaminases increased, |
||||
351 | 25067893 |
CA |
2 | |
Helicobacter infection, Lower limb fracture, Lupus vulgaris, Sleep disorder, Eye injury, Headache, Blood cholesterol increased, Confusional state, Abdominal pain upper, Infusion related reaction, Therapeutic response decreased, Pain, Drug ineffective, Vomiting, Psoriatic arthropathy, Anxiety, Glossodynia, Lower respiratory tract infection, Irritable bowel syndrome, Condition aggravated, Product use issue, Rheumatoid arthritis, Leukopenia, Contraindicated product administered, Sleep disorder due to general medical condition, insomnia type, Pericarditis, Fatigue, General physical health deterioration, Dizziness, Folliculitis, Anti-cyclic citrullinated peptide antibody positive, Type 2 diabetes mellitus, Road traffic accident, Deep vein thrombosis postoperative, Stomatitis, Urticaria, Hand deformity, Injury, Discomfort, Alopecia, Ulcer haemorrhage, Drug hypersensitivity, Maternal exposure during pregnancy, Synovitis, Impaired healing, Hypertension, Prescribed overdose, Gastrointestinal disorder, Product use in unapproved indication, Diarrhoea, Rash pruritic, Pemphigus, Peripheral swelling, Nasopharyngitis, Muscle injury, Intentional product use issue, Pyrexia, Systemic lupus erythematosus, Weight increased, Sinusitis, Gait inability, Duodenal ulcer perforation, Asthma, Chest pain, Off label use, Swelling, Autoimmune disorder, Fibromyalgia, Drug intolerance, Liver disorder, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROXYCHLOROQUINE, TOFACITINIB, TOFACITINIB, OXYCODONE, LEFLUNOMIDE, ADALIMUMAB, ABATACEPT, ABATACEPT, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CALCIUM GLUCONATE, INFLIXIMAB, INFLIXIMAB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CALCIUM CARBONATE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, VITAMIN C, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, MAGNESIUM, CAFFEINE, LORAZEPAM, ERGOCALCIFEROL, LORAZEPAM, LANSOPRAZOLE, LISINOPRIL, |
||||
352 | 25068081 |
GB |
60 | 2 |
Gastrointestinal disorder, Malaise, |
||||
EZETIMIBE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROPRANOLOL HYDROCHLORIDE, ROSUVASTATIN, ESTRADIOL, LANSOPRAZOLE, |
||||
353 | 25068621 |
US |
||
Gastrointestinal disorder, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
354 | 25068787 |
US |
73 | 2 |
Gastrointestinal disorder, |
||||
DUPILUMAB, |
||||
355 | 25069706 |
US |
59 | 2 |
Gastrointestinal disorder, Off label use, |
||||
BINIMETINIB, ENCORAFENIB, DULAGLUTIDE, |
||||
356 | 25070240 |
CN |
57 | 2 |
Gastrointestinal disorder, Vomiting, Nausea, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
357 | 25070247 |
CN |
43 | 2 |
Gastrointestinal disorder, Nausea, Vomiting, Insomnia, Decreased appetite, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXAMETHASONE SODIUM PHOSPHATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
358 | 25070269 |
US |
40 | 1 |
Gastrointestinal disorder, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SILDENAFIL CITRATE, SILDENAFIL, APIXABAN, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
359 | 25070272 |
AR |
46 | 2 |
Gastrointestinal disorder, Skin disorder, Inflammation, Diarrhoea, Headache, Application site inflammation, Pruritus, Erythema, Dermatitis atopic, Glossitis, Gastrointestinal pain, Musculoskeletal pain, Oral mucosal blistering, Perioral dermatitis, Hypersensitivity, |
||||
360 | 25070491 |
US |
2 | |
Multiple sclerosis relapse, Polymenorrhoea, Memory impairment, Headache, Hangover, Diplopia, Pain, Rhinorrhoea, Arthralgia, Urticaria, Hyperkeratosis, Chest discomfort, Dyspnoea, Gastrointestinal disorder, |
||||
OFATUMUMAB, |
||||
361 | 25070734 |
US |
54 | 1 |
Gastrointestinal disorder, Condition aggravated, Pain, |
||||
DUPILUMAB, |
||||
362 | 25071196 |
US |
1 | |
Seizure, Mitral valve incompetence, Lethargy, Gastrointestinal disorder, Personality change, Decreased appetite, Teething, Ear infection, Movement disorder, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
363 | 25071297 |
CN |
||
Death, Feeding disorder, Gastrointestinal disorder, Myelosuppression, Drug ineffective, |
||||
ABEMACICLIB, |
||||
364 | 25071519 |
PT |
2 | |
Leukopenia, Post procedural hypothyroidism, Polymyalgia rheumatica, HIV infection, Peptic ulcer, Dry mouth, Tongue discomfort, Mouth injury, Joint stiffness, Pain, Tinnitus, Gastrointestinal disorder, Chronic respiratory disease, Condition aggravated, Paroxysmal extreme pain disorder, Gastritis, Arthralgia, Osteopenia, Chronic obstructive pulmonary disease, Nasal polyps, Rhinitis allergic, Degenerative bone disease, Dyslipidaemia, Weight increased, Asthma, Bundle branch block left, Alopecia, Abnormal dreams, Confusional arousal, Helicobacter infection, Osteoporosis, Gingivitis, Anxiety, Middle insomnia, |
||||
LEVOTHYROXINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ROSUVASTATIN, EFAVIRENZ, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PANTOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
365 | 25073445 |
46 | 2 | |
Constipation, Gastrointestinal disorder, Anxiety, Suicidal ideation, Thyroid function test abnormal, Eosinophilic oesophagitis, Secretion discharge, Inflammation, Abdominal pain, Cough, |
||||
DUPILUMAB, |
||||
366 | 25061457 |
US |
||
Gastrointestinal disorder, |
||||
PIRFENIDONE, |
||||
367 | 25061597 |
US |
56 | 2 |
Gastrointestinal disorder, Nervous system disorder, |
||||
LENALIDOMIDE, BORTEZOMIB, IPRATROPIUM BROMIDE, LOSARTAN POTASSIUM, ATORVASTATIN CALCIUM, DESVENLAFAXINE SUCCINATE, METOPROLOL SUCCINATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALPRAZOLAM, ALBUTEROL SULFATE, |
||||
368 | 25061847 |
US |
||
Gastrointestinal disorder, Diarrhoea, |
||||
APREMILAST, |
||||
369 | 25061989 |
US |
2 | |
Photopsia, Abdominal discomfort, Gastrointestinal disorder, Disease progression, |
||||
NIROGACESTAT, |
||||
370 | 25062038 |
US |
7 | 2 |
Gastrointestinal disorder, Abdominal discomfort, Gastrooesophageal reflux disease, Diarrhoea, Incorrect dose administered, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, |
||||
371 | 25062070 |
RU |
2 | |
Systemic lupus erythematosus, Hallucination, Vomiting, Gastrointestinal disorder, Stomatitis, Disease recurrence, |
||||
ETANERCEPT, ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, |
||||
372 | 25062148 |
US |
63 | 2 |
Neoplasm, Gastrointestinal disorder, |
||||
RISANKIZUMAB-RZAA, |
||||
373 | 25062274 |
US |
77 | 2 |
Nausea, Diarrhoea, Gastrointestinal disorder, Pain in extremity, Headache, Vomiting, Flushing, Therapy partial responder, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCHLOROTHIAZIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, LEVOTHYROXINE, TADALAFIL, ERGOCALCIFEROL, PROPRANOLOL HYDROCHLORIDE, BETAMETHASONE DIPROPIONATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, RIVAROXABAN, OXYGEN, 0XYGEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, VALSARTAN, EMPAGLIFLOZIN, SEMAGLUTIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
374 | 25062421 |
CZ |
43 | 2 |
Illness, Respiratory tract infection, Gastrointestinal disorder, COVID-19, Nasopharyngitis, |
||||
ADALIMUMAB, |
||||
375 | 25062462 |
US |
38 | 2 |
Hysterectomy, Neurogenic bladder, Hypotonic urinary bladder, Gastrointestinal disorder, Internal haemorrhage, Excessive granulation tissue, Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Anxiety, Stress, Mood swings, Weight increased, Sexual activity decreased, Urinary incontinence, Hypertonic bladder, Procedural pain, Pelvic floor dysfunction, Hormone level abnormal, Gastrooesophageal reflux disease, Neuralgia, Constipation, Inflammatory pain, Nausea, Vomiting, Depression, Muscle spasms, Heavy menstrual bleeding, Abdominal pain, Pain, Urinary tract infection, Abdominal discomfort, |
||||
COPPER, |
||||
376 | 25062887 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, APREMILAST, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, APREMILAST, CANDESARTAN CILEXETIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
377 | 25063068 |
CN |
||
Gastrointestinal disorder, |
||||
HYDROXYCHLOROQUINE, |
||||
378 | 25063193 |
US |
||
Muscle spasms, Peripheral swelling, Chest discomfort, Hiccups, Gastrointestinal disorder, Dyspnoea, Fatigue, |
||||
SELINEXOR, METHADONE, GABAPENTIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, LISINOPRIL, POMALIDOMIDE, APIXABAN, TAMSULOSIN HYDROCHLORIDE, |
||||
379 | 25063537 |
IN |
78 | 1 |
Jaundice, Enteritis, Nephritis, Prostatomegaly, Vomiting, Gastrointestinal disorder, Pyrexia, |
||||
ATEZOLIZUMAB, |
||||
380 | 25063670 |
US |
62 | 2 |
Illness, Dysstasia, Gastrointestinal disorder, Nausea, |
||||
AVAPRITINIB, |
||||
381 | 25063783 |
40 | 2 | |
Feeling abnormal, Gastrointestinal disorder, Abdominal pain, Abdominal pain, Constipation, Fluid retention, Deep vein thrombosis, Abdominal distension, Heavy menstrual bleeding, Condition aggravated, |
||||
DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL AND ETHINYL ESTRADIOL, APIXABAN, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LISDEXAMFETAMINE, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, |
||||
382 | 25063875 |
US |
||
Atrial fibrillation, Gastrointestinal disorder, Gastrooesophageal reflux disease, Prostatitis, Haemorrhage, |
||||
RELUGOLIX, RELUGOLIX, APIXABAN, |
||||
383 | 25063951 |
US |
2 | |
Eye disorder, Gastrointestinal disorder, |
||||
PEMBROLIZUMAB, BELZUTIFAN, BELZUTIFAN, |
||||
384 | 25063963 |
US |
68 | 2 |
Dry skin, Gastrointestinal disorder, |
||||
LENALIDOMIDE, ZOLPIDEM TARTRATE, AMOXICILLIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMOXICILLIN AND CLAVULANATE POTASSIUM, CETIRIZINE HCL, CETIRIZINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, GABAPENTIN, LENALIDOMIDE, |
||||
385 | 25063971 |
DE |
61 | 2 |
Neutrophil count decreased, Gastrointestinal disorder, Pleural effusion, Diarrhoea, Leukopenia, Stomatitis, Nausea, Blood disorder, Transaminases increased, |
||||
CARBOPLATIN, DURVALUMAB, DURVALUMAB, PEMETREXED, PEMETREXED DISODIUM, TREMELIMUMAB, TREMELIMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, APREPITANT, FOSAPREPITANT DIMEGLUMINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, FOLIC ACID, GRANISETRON HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PEGFILGRASTIM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, UMECLIDINIUM, |
||||
386 | 25064139 |
US |
45 | 1 |
Diarrhoea, Nausea, Gastrointestinal disorder, Decreased appetite, |
||||
APREMILAST, |
||||
387 | 25064444 |
DE |
||
Gastrointestinal disorder, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
388 | 25064476 |
CA |
7 | 2 |
Asthma, Cough, Dust allergy, Frustration tolerance decreased, Gastrointestinal disorder, Illness, Insomnia, Lymphadenitis, Middle insomnia, Nasal congestion, Nasopharyngitis, Oropharyngeal pain, Pyrexia, Respiratory tract infection, Sialoadenitis, Sinusitis, Viral infection, Vomiting, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMOXICILLIN, FLUTICASONE FUROATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
389 | 25064478 |
CN |
43 | 2 |
Gastrointestinal disorder, Vomiting, Nausea, Glare, Dizziness, Dysstasia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EPIRUBICIN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
390 | 25064523 |
CA |
66 | 2 |
Asthma, Blood pressure systolic increased, Bronchitis, COVID-19, Cough, Ear pruritus, Forced expiratory volume decreased, Gastroenteritis norovirus, Gastrointestinal disorder, Infection, Injection site bruising, Injection site haemorrhage, Injection site pain, Injection site swelling, Malaise, Pneumonia, Sinusitis, Sleep disorder, Urinary tract infection, Weight decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LOSARTAN POTASSIUM, HYDROXYCHLOROQUINE SULFATE, MONTELUKAST SODIUM, TELMISARTAN, ALBUTEROL SULFATE, |
||||
391 | 25064530 |
CN |
||
Death, Feeding disorder, Gastrointestinal disorder, Myelosuppression, Drug ineffective, |
||||
ABEMACICLIB, |
||||
392 | 25064534 |
CA |
44 | 2 |
Bone erosion, Breast cancer stage II, Bursitis, C-reactive protein, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Confusional state, Contusion, Crohn^s disease, Adjustment disorder with depressed mood, Deep vein thrombosis postoperative, Disability, Dry mouth, Dyspepsia, Dyspnoea, Exostosis, Facet joint syndrome, Feeling hot, Fluid retention, Frequent bowel movements, Anti-cyclic citrullinated peptide antibody, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General symptom, Grip strength decreased, Hepatic cirrhosis, Hypercholesterolaemia, Ill-defined disorder, Impaired healing, Amnesia, Incorrect route of product administration, Infection, Inflammation, Insomnia, Irritable bowel syndrome, Joint stiffness, Laryngitis, Lip dry, Liver disorder, Lower limb fracture, Anxiety, Lower respiratory tract infection, Lung disorder, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Migraine, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Arthritis, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Night sweats, Pain in extremity, Paraesthesia, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Asthma, Prescribed underdose, Pruritus, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash vesicular, Red blood cell sedimentation rate increased, Vaginal discharge, Sleep disorder, Autoimmune disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Therapy non-responder, Thrombocytopenia, Underdose, Urticaria, Weight decreased, Weight increased, Wound infection, Back disorder, X-ray abnormal, |
||||
TRAMADOL HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, METHYLPREDNISOLONE, MESALAMINE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, NAPROXEN, NAPROXEN SODIUM, NEOMYCIN OINTMENT, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PHENYLEPHRINE HYDROCHLORIDE, RAMIPRIL, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, METHYLPREDNISOLONE SODIUM SUCCINATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CALCIUM CARBONATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOFACITINIB, |
||||
393 | 25064607 |
CA |
67 | |
Off label use, Gastrooesophageal reflux disease, Gastrointestinal disorder, Thrombosis, Hernia, Malaise, |
||||
ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, RIVAROXABAN, |
||||
394 | 25064795 |
US |
1 | |
Gastrointestinal disorder, Peritonitis, |
||||
DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
395 | 25064910 |
US |
||
Gastrointestinal disorder, |
||||
CHOLESTYRAMINE, |
||||
396 | 25065312 |
AU |
42 | 2 |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
397 | 25065341 |
IT |
36 | 2 |
Gastrointestinal disorder, Drug ineffective, Alopecia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, ABATACEPT, CYCLOSPORINE, RITUXIMAB, LEFLUNOMIDE, GOLIMUMAB, BARICITINIB, INFLIXIMAB, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, |
||||
398 | 25065402 |
US |
||
Ostomy bag placement, Gastrointestinal disorder, Product residue present, |
||||
UPADACITINIB, |
||||
399 | 25065894 |
US |
2 | |
Gastrointestinal disorder, Off label use, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
400 | 25068201 |
59 | 2 | |
Loss of consciousness, Fall, Contusion, Head injury, Skin swelling, Migraine, Hyperacusis, Concussion, Withdrawal syndrome, Gastrointestinal disorder, Dizziness, |
||||
TIRZEPATIDE, BUPROPION HYDROCHLORIDE, BUPROPION, FLUOXETINE HYDROCHLORIDE, ALPRAZOLAM, BACLOFEN, CELECOXIB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28